1. Aseptic meningitis after SARS-CoV-2 Pfizer/BioNTech vaccination.
- Author
-
Dupon V, Arnaert S, Van Haute E, Vulsteke F, Diet G, and De Schoenmakere G
- Subjects
- Female, Humans, Adult, SARS-CoV-2, BNT162 Vaccine, Vaccination, Methylprednisolone, RNA, Messenger, Meningitis, Aseptic diagnosis, Meningitis, Aseptic etiology, COVID-19 prevention & control
- Abstract
Objective: Aseptic meningitis is a rare, but possible severe side effect after SARS-CoV-2 Pfizer/BioNTech vaccination., Case Presentation: Recently, a first case of aseptic meningitis after the first shot of mRNA-BNT162b2 SARS-CoV-2 (Pfizer/BioNTech) vaccine was reported. We present the first case of a 34-year-old woman without relevant medical history developing aseptic meningitis after her 2
nd Pfizer/BioNTech vaccination. She was admitted with severe headache and fever for 5 days prior to her presentation at the emergency department. An extensive work-up of the clinical problem could narrow the differential diagnosis. Symptoms resolved after methylprednisolone therapy., Conclusion: This case highlights a rare but important side effect after vaccination that primary physicians and neurologists should be aware of in order to identify and efficiently manage these patients.- Published
- 2022
- Full Text
- View/download PDF